‹Return to Search Results

Drug Details

Drug Number:	499/08
Drug Name:	ibritumomab tiuxetan 1.6mg/ml (Zevalin)
Drug Manufacturer:	Bayer plc
BNF Category:	Malignant disease and immunosuppression
Submission type :	Non submission
Date Advice Issued:	11th August 2008
Indication:	for the treatment of follicular lymphoma

Drug Advice

ibritumomab tiuxetan 1.6mg/ml (Zevalin)

Minutes

Read the minutes

Notes

‹Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product

SEARCH FOR A DRUG

UNKNOWN - All BNF Categories - AnaesthesiaCardiovascular systemCentral nervous systemEar, nose and oropharynxEndocrine systemEyeGastro-intestinal systemImmunological products and vaccinesInfectionsMalignant disease and immunosuppressionMusculoskeletal and joint diseasesNutrition and bloodObstetrics, gynaecology, and urinary-tract disordersRespiratory systemSkin

UNKNOWN - All Types of Submission - Abbreviated SubmissionFull submissionIRPNon submissionResubmission

Help on how to improve your search.